IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Charlotte Syrykh; Berta Pons-Brun; Núria Russiñol; Heribert Playa-Albinyana; Tycho Baumann; Martí Duran-Ferrer; Marta Kulis; Anna Carbó-Meix; Pablo Mozas; Miguel Alcoceba; Marcos González; Almudena Navarro-Bailón; Enrique Colado; Ángel R. Payer; Marta Aymerich; María J. Terol; Junyan Lu; Binyamin A. Knisbacher; Cynthia K. Hahn; Sílvia Ruiz-Gaspà; Anna Enjuanes; Catherine J. Wu; Gad Getz; Thorsten Zenz; Armando López-Guillermo; José I. Martín-Subero; Dolors Colomer; Julio Delgado; Elías Campo; Ferran Nadeu

doi:10.1182/bloodadvances.2023010132

IGLV3-21^R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Charlotte Syrykh, Berta Pons-Brun, Núria Russiñol, Heribert Playa-Albinyana, Tycho Baumann, Martí Duran-Ferrer, Marta Kulis, Anna Carbó-Meix, Pablo Mozas, Miguel Alcoceba, Marcos González, Almudena Navarro-Bailón, Enrique Colado, Ángel R. Payer, Marta Aymerich, María J. Terol, Junyan Lu, Binyamin A. Knisbacher, Cynthia K. Hahn, Sílvia Ruiz-GaspàAnna Enjuanes, Catherine J. Wu, Gad Getz, Thorsten Zenz, Armando López-Guillermo, José I. Martín-Subero, Dolors Colomer, Julio Delgado, Elías Campo, Ferran Nadeu

The Mina and Everard Goodman Faculty of Life Sciences - at Bar-Ilan University

Bar-Ilan University

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	7384-7391
Number of pages	8
Journal	Blood Advances
Volume	7
Issue number	23
DOIs	https://doi.org/10.1182/bloodadvances.2023010132
State	Published - 12 Dec 2023

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1182/bloodadvances.2023010132

Cite this

Syrykh, C., Pons-Brun, B., Russiñol, N., Playa-Albinyana, H., Baumann, T., Duran-Ferrer, M., Kulis, M., Carbó-Meix, A., Mozas, P., Alcoceba, M., González, M., Navarro-Bailón, A., Colado, E., Payer, Á. R., Aymerich, M., Terol, M. J., Lu, J., Knisbacher, B. A., Hahn, C. K., ... Nadeu, F. (2023). IGLV3-21^R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances, 7(23), 7384-7391. https://doi.org/10.1182/bloodadvances.2023010132

@article{e8bfb330e1ba43f68eeeed5c3e084244,

title = "IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia",

author = "Charlotte Syrykh and Berta Pons-Brun and N{\'u}ria Russi{\~n}ol and Heribert Playa-Albinyana and Tycho Baumann and Mart{\'i} Duran-Ferrer and Marta Kulis and Anna Carb{\'o}-Meix and Pablo Mozas and Miguel Alcoceba and Marcos Gonz{\'a}lez and Almudena Navarro-Bail{\'o}n and Enrique Colado and Payer, \{{\'A}ngel R.\} and Marta Aymerich and Terol, \{Mar{\'i}a J.\} and Junyan Lu and Knisbacher, \{Binyamin A.\} and Hahn, \{Cynthia K.\} and S{\'i}lvia Ruiz-Gasp{\`a} and Anna Enjuanes and Wu, \{Catherine J.\} and Gad Getz and Thorsten Zenz and Armando L{\'o}pez-Guillermo and Mart{\'i}n-Subero, \{Jos{\'e} I.\} and Dolors Colomer and Julio Delgado and El{\'i}as Campo and Ferran Nadeu",

year = "2023",

month = dec,

day = "12",

doi = "10.1182/bloodadvances.2023010132",

language = "الإنجليزيّة",

volume = "7",

pages = "7384--7391",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "23",

}

Syrykh, C, Pons-Brun, B, Russiñol, N, Playa-Albinyana, H, Baumann, T, Duran-Ferrer, M, Kulis, M, Carbó-Meix, A, Mozas, P, Alcoceba, M, González, M, Navarro-Bailón, A, Colado, E, Payer, ÁR, Aymerich, M, Terol, MJ, Lu, J, Knisbacher, BA, Hahn, CK, Ruiz-Gaspà, S, Enjuanes, A, Wu, CJ, Getz, G, Zenz, T, López-Guillermo, A, Martín-Subero, JI, Colomer, D, Delgado, J, Campo, E & Nadeu, F 2023, 'IGLV3-21^R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia', Blood Advances, vol. 7, no. 23, pp. 7384-7391. https://doi.org/10.1182/bloodadvances.2023010132

TY - JOUR

T1 - IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

AU - Syrykh, Charlotte

AU - Pons-Brun, Berta

AU - Russiñol, Núria

AU - Playa-Albinyana, Heribert

AU - Baumann, Tycho

AU - Duran-Ferrer, Martí

AU - Kulis, Marta

AU - Carbó-Meix, Anna

AU - Mozas, Pablo

AU - Alcoceba, Miguel

AU - González, Marcos

AU - Navarro-Bailón, Almudena

AU - Colado, Enrique

AU - Payer, Ángel R.

AU - Aymerich, Marta

AU - Terol, María J.

AU - Lu, Junyan

AU - Knisbacher, Binyamin A.

AU - Hahn, Cynthia K.

AU - Ruiz-Gaspà, Sílvia

AU - Enjuanes, Anna

AU - Wu, Catherine J.

AU - Getz, Gad

AU - Zenz, Thorsten

AU - López-Guillermo, Armando

AU - Martín-Subero, José I.

AU - Colomer, Dolors

AU - Delgado, Julio

AU - Campo, Elías

AU - Nadeu, Ferran

PY - 2023/12/12

Y1 - 2023/12/12

UR - http://www.scopus.com/inward/record.url?scp=85179605872&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2023010132

DO - 10.1182/bloodadvances.2023010132

M3 - رسالة

C2 - 37505099

SN - 2473-9529

VL - 7

SP - 7384

EP - 7391

JO - Blood Advances

JF - Blood Advances

IS - 23

ER -

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this

IGLV3-21^R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia